Immunocore reports fourth quarter and full year 2025 financial results and provides a business update KIMMTRAK (tebentafusp-tebn) Q4 net sales of $104.5 million and $400.0 million for full year 2025; ...

Secondhand smoke is also harmful during pregnancy, as it can cause lower birth weight and even lead to premature birth.

Fulcrum plans to initiate a potential registration-enabling trial in the second half of 2026, pending feedback from the FDA ...

Jury Returns Verdict Following Four-Week Trial Involving 2017 Labor and Delivery While nothing can undo Dylan’s injury, ...

Data from the pivotal ENERGY trial showed IMAAVY® produced a rapid and durable hemoglobin responsea in wAIHA Currently no FDA-approved therapies are available for wAIHA ...